Abstract:Objective To explore the relation of alveolar typeⅡ cell development and SP mRNAs expression in fetal rabbit lung, and to investigate the regulatory effects of epidermal growth factor (EGF), thyrotropin releasing hormone (TRH), and dexamethasone (Dex) on them. Methods Pregnant rabbits were divided into EGF treated, TRH treated, Dex treated, and control groups with 16 in each. EGF, TRH, Dex, and saline were given intravenously respectively, at 22-24 d or 24-26 d after gestation. Ultrastructure of alveolar type Ⅱ cells in fetal lungs was observed using electron microscopy, and the levels of SP A, SP B, and SP C mRNA were detected by RT PCR and Southern blotting. Results Alveolar type Ⅱ cells of fetal lungs in EGF, TRH, and Dex treated groups contained more lamellar bodies and less glycogen than those in control group at 27 d after gestation. SP B mRNA levels from EGF, TRH, and Dex treated fetal lungs were also significantly higher than those from control group, but no significant difference of SP A and SP C mRNA levels were found among the four groups. In 25 d lung, only few type Ⅱ cell in Dex treated group contained a few small lamellar bodies, and no lamellar body was found in other treated groups and control group. However, glycogen was very abundant in every group. Also, only Dex appeared to increase the expression of SP B mRNA at a lower level, and SP B mRNA was undetectable in other groups in 25 d lung. But the expression of SP A and SP C mRNA was at a high level in all groups. Conclusion The time of expression for SP A and SP C mRNA is earlier than that of SP B mRNA in fetal rabbit lung. SP B mRNA expression is lower than SP A or SP C mRNA expression. The accumulation of detectable SP B mRNA and the increase of SP B mRNA level correspond to the appearance and the increment of lamellar body numbers in type Ⅱ cell. It suggests that the increase of SP B mRNA level may be a marker of differentiation and mature of type Ⅱ cell in fetal lung. Prenatal maternal treatment with Dex, EGF, and TRH can promote the development of type Ⅱ cell and increase the expression of SP B mRNA in rabbit fatal lung, but the up regulation of Dex may be more significant at the early stage of gestation.

The expression of the surfactant proteins SP-A and SP-B during postnatal alveolarization of the rat lung

Changing Metabolism of Surfactant in Alveolar Type Ⅱ Cells from Old Rats

Mechanosensitive Channels TMEM63A and TMEM63B Mediate Lung Inflation-Induced Surfactant Secretion

Surfactant Protein B Deficiency Induced High Surface Tension: Relationship between Alveolar Micromechanics, Alveolar Fluid Properties and Alveolar Epithelial Cell Injury

Developmental and genetic regulation of human surfactant protein B in vivo.

Human surfactant protein B: structure, function, regulation, and genetic disease

[Changes of Aquaporin Expression During Lung Development in Rats].

Effects of ageing on surfactant protein C mRNA expression

[The Influence of Surfactant on the Alveolar Morphology in Premature Rabbits].

Effects of Various Forms of Surfactant Protein C on Tidal Volume in Ventilated Immature Newborn Rabbits.

Morphological Research of Lung Development in Fetal Rat

Dynamic Changes of Surfactant Protein-D and Clara Cell Protein Expressions in Lung Tissue and Bronchoalveolar Lavage Fluid of Silica-Treated Rats

Relation and Regulation of Development of Alveolar Type II Cell and Expression of SPmRNAs in Fetal Rabbit Lung

What is new in synthetic lung surfactant protein technology?

Pepsinogen C proteolytic processing of surfactant protein B

Early life surfactant protein-D levels in bronchoalveolar lavage fluids of extremely preterm neonates

Ultrastructural analysis of lamellar bodies in type II alveolar epithelial cells in the human lung

“SP-G”, a Putative New Surfactant Protein – Tissue Localization and 3D Structure

Investigation and its significance of phospholipid in alveolar surfactant with acquired pectus excavatum in rats

ErbB deletion effect on pulmonary intracellular surfactant distribution

Cell-specific modulation of surfactant proteins by ambroxol treatment